Literature DB >> 21489887

Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.

Stefanie Kuerten1, Robert Pauly, Andrea Rottlaender, Michael Rodi, Traugott L Gruppe, Klaus Addicks, Magdalena Tary-Lehmann, Paul V Lehmann.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is frequently used for studies of multiple sclerosis (MS). Because in most EAE models T cells mediate the pathology in the absence of B cells/autoantibodies, the notion has evolved that also MS may be a primarily T cell-mediated disease. We have previously introduced MBP-PLP fusion protein (MP4)-induced EAE in C57BL/6 mice. Here we show that the disease in this model is antibody-dependent. Immunization of B cell-deficient mice did not induce EAE. When such B cell-deficient mice were, however, injected with MBP/PLP-specific antibodies in addition to the immunization with MP4, they developed disease of a severity and course that was similar to the wild-type mice. The deposition of antibodies in demyelinated lesions provided further evidence for the contribution of MBP/PLP-specific antibodies to CNS lesion formation. Based upon these data we suggest a two-stage model for the involvement of MBP/PLP-specific antibodies in autoimmune CNS pathology.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489887     DOI: 10.1016/j.clim.2011.03.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

1.  Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.

Authors:  Andrea Schampel; Oleg Volovitch; Tobias Koeniger; Claus-Jürgen Scholz; Stefanie Jörg; Ralf A Linker; Erhard Wischmeyer; Marie Wunsch; Johannes W Hell; Süleyman Ergün; Stefanie Kuerten
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-05       Impact factor: 11.205

Review 2.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

3.  Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis.

Authors:  Yonglian Sun; Ivan Peng; Kate Senger; Kajal Hamidzadeh; Mike Reichelt; Miriam Baca; Ronald Yeh; Maria N Lorenzo; Andrew Sebrell; Christopher Dela Cruz; Lucinda Tam; Racquel Corpuz; Jiansheng Wu; Tao Sai; Merone Roose-Girma; Søren Warming; Mercedesz Balazs; Lino C Gonzalez; Patrick Caplazi; Flavius Martin; Jason Devoss; Ali A Zarrin
Journal:  Autoimmunity       Date:  2013-01-18       Impact factor: 2.815

4.  CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.

Authors:  Damiano M Rovituso; Laura Scheffler; Marie Wunsch; Christoph Kleinschnitz; Sebastian Dörck; Jochen Ulzheimer; Antonios Bayas; Lawrence Steinman; Süleyman Ergün; Stefanie Kuerten
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

5.  Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination.

Authors:  Carsten Tue Berg; Reza Khorooshi; Nasrin Asgari; Trevor Owens
Journal:  J Neuroinflammation       Date:  2017-06-24       Impact factor: 8.322

Review 6.  Hypersensitivity Responses in the Central Nervous System.

Authors:  Reza Khorooshi; Nasrin Asgari; Marlene Thorsen Mørch; Carsten Tue Berg; Trevor Owens
Journal:  Front Immunol       Date:  2015-10-07       Impact factor: 7.561

7.  Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.

Authors:  Thomas Breakell; Sabine Tacke; Verena Schropp; Henrik Zetterberg; Kaj Blennow; Eduard Urich; Stefanie Kuerten
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.